During a lengthy interview broadcast on alternative media platforms, Jean-Marc Sabatier shared his views on several current public health topics, including hantaviruses, the Ebola virus, and Alpha-Gal syndrome.
Hantaviruses Under Scrutiny
The interview first focused on hantaviruses, a family of viruses that can cause pulmonary syndromes or hemorrhagic fevers. Jean-Marc Sabatier noted that these viruses are generally transmitted through contact with the feces, urine, or saliva of infected rodents and are not easily spread from person to person.
According to Sabatier, Moderna’s development of an mRNA vaccine targeting certain hantavirus strains as early as 2024 raises questions, particularly because these viruses are considered to have limited pandemic potential. He also described several biological mechanisms associated with these infectious agents and discussed laboratory research involving pseudoviruses.
The speakers emphasized that, based on the information available to them, the number of reported cases in Europe remains limited and that the situation does not currently warrant major concern.
Ebola: Vigilance and Debate Over Vaccination Strategies
The second part of the interview addressed the Ebola virus, particularly the Bundibugyo strain, which is currently being monitored in Central Africa.
Jean-Marc Sabatier reviewed the biological characteristics of the virus, its high fatality rate under certain circumstances, and its modes of transmission, primarily through contact with bodily fluids. He stressed that Ebola outbreaks have historically been contained through targeted public health measures.
The two participants also discussed funding for vaccine research directed at this specific strain. They expressed skepticism about the possibility of large-scale vaccination campaigns being implemented if the virus were to spread beyond Africa.
In addition, several potential treatments were mentioned, including certain monoclonal antibodies and older medications such as ivermectin and hydroxychloroquine, although their effectiveness remains a subject of debate within the scientific community.
Alpha-Gal Syndrome and Red Meat Allergy
The third topic concerned Alpha-Gal syndrome, a red meat allergy that can develop following bites from certain tick species, particularly the Lone Star tick, which is found primarily in North America.
Jean-Marc Sabatier explained that the condition results from an immune reaction to a sugar molecule known as galactose-α-1,3-galactose, which is present in most mammals but absent in humans.
During the discussion, the participants referred to various claims circulating on social media regarding Bill Gates’s alleged involvement in programs related to ticks or synthetic meat. They suggested that connections between these topics might exist, although no direct evidence was presented during the interview.
Ongoing Criticism of Public Health Institutions
Throughout the conversation, the participants expressed skepticism toward certain public health institutions, including the World Health Organization (WHO), regulatory agencies, and major pharmaceutical companies.
Jean-Marc Sabatier specifically criticized the development of mRNA vaccines and argued that dissenting voices face difficulties being heard within scientific and media circles. He stated that he himself has experienced a form of marginalization because of his views.
A Call for Caution
In conclusion, despite the concerns raised during the interview, Jean-Marc Sabatier encouraged listeners not to panic in response to new public health alerts. According to him, it is important to maintain a critical mindset, consult multiple sources of information, and closely monitor evolving epidemiological situations without resorting to alarmism.
Jean-Marc Sabatier, Director of Research at the CNRS, holds a PhD in cell biology and microbiology and a Habilitation à diriger des recherches (HDR) in biochemistry